BioRestorative Therapies Inc (BRTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.06M
Last updated: Nov 17, 2026 at 11:00 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 28.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 35.7, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about BRTX
GNG News
All BRTX news- BRTXMaxim Group downgrades BioRestorative Therapies (BRTX) to Hold
UpdatedHistorical
News
BRTX Valuation
- P/B
- 8.3x
BRTX Profitability: Margins, ROIC and FCF
BioRestorative Therapies (BRTX) has a gross margin of 92.1%, an operating margin of -3975.0% and a net margin of 0.0%. It posts -289.9% ROIC and a -3324.6% FCF margin.
- Gross margin
- 92.1%
- Operating margin
- -3975.0%
- Net margin
- 0.0%
- ROIC
- -289.9%
- ROE
- -241.1%
- FCF margin
- -3324.6%
BioRestorative Therapies Competitors
The companies most similar to BioRestorative Therapies (BRTX) include Revelation Biosciences, Bone Biologics and Ernexa Therapeutics.
Sector: Healthcare
Companies most similar to BioRestorative TherapiesBRTX Bull Case vs Bear Case
Bull case
- BRTX beat EPS estimates in 75.0% of its last 8 reported quarters.
Bear case
- BRTX's quarterly revenue changed -7.3% year over year.
BRTX Earnings: Beat Rate and Next Report
BioRestorative Therapies (BRTX) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 24, 2027.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- -6.8%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$2.04
BRTX Earnings Date
BRTX reports Mar 24, 2027. The date is estimated.
BRTX Earnings Call
The latest BRTX earnings call transcript on file is labeled 2025Q3.
Read the 2025Q3 transcriptBRTX ETF Holders
GNG tracks 1 ETF that holds BRTX.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 11, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About BRTX
When does BRTX report earnings?
BioRestorative Therapies Inc (BRTX) is expected to report earnings on Mar 24, 2027.
Does BRTX pay dividends?
BioRestorative Therapies Inc (BRTX) does not currently pay a regular dividend.
What is BRTX's market cap?
BioRestorative Therapies Inc (BRTX) has a market capitalization of $2.06M with a current stock price of $1.42.
BRTX pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.